Publicacions en què col·labora amb MARÍA ISABEL GONZÁLEZ TOMÉ (36)

2022

  1. Children living with HIV in Europe: do migrants have worse treatment outcomes?

    HIV Medicine, Vol. 23, Núm. 2, pp. 186-196

2021

  1. Effects of perinatal HIV-infection on the cortical thickness and subcortical gray matter volumes in young adulthood

    Medicine, Vol. 100, Núm. 15, pp. e25403

  2. Malignancies among children and young people with HIV in Western and Eastern Europe and Thailand the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) study group

    AIDS, Vol. 35, Núm. 12, pp. 1973-1985

2020

  1. Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Impact of HIV on the health-related quality of life in youth with perinatally acquired HIV

    World Journal of Pediatrics, Vol. 15, Núm. 5, pp. 492-498

  2. Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid

    Journal of Maternal-Fetal and Neonatal Medicine, Vol. 32, Núm. 4, pp. 617-625

  3. Prognostic factors of a lower CD4/CD8 ratio in long term viral suppression HIV infected children

    PLoS ONE, Vol. 14, Núm. 8

  4. Sociodemographic changes and trends in the rates of new perinatal HIV diagnoses and transmission in Spain from 1997 to 2015

    PLoS ONE, Vol. 14, Núm. 10

2018

  1. Sleep Profile and Self-Reported Neuropsychiatric Symptoms in Vertically HIV-Infected Adolescents on cART

    Journal of Pediatric Infectious Diseases, Vol. 13, Núm. 4, pp. 300-307

2017

  1. Dexamethasone for Parapneumonic Pleural Effusion: A Randomized, Double-Blind, Clinical Trial

    Journal of Pediatrics, Vol. 185, pp. 117-123.e6

  2. Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe

    HIV Medicine, Vol. 18, Núm. 3, pp. 171-180

  3. Low Bone Mineral Density in Vertically HIV-infected Children and Adolescents: Risk Factors and the Role of T-cell Activation and Senescence

    Pediatric Infectious Disease Journal

2016

  1. Disease disclosure, treatment adherence, and behavioural profile in a cohort of vertically acquired HIV-infected adolescents. NeuroCoRISpeS study

    AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, Vol. 28, Núm. 1, pp. 124-130

2015

  1. La formación del residente: valoración de la rotación internacional en diferentes contextos

    Acta Pediatrica Espanola, Vol. 73, Núm. 2, pp. 34-39

  2. La formación del residente: valoración de la rotación internacional en diferentes contextos: valoración de la rotación internacional en diferentes contextos

    Acta pediátrica española, Vol. 73, Núm. 2, pp. 34-39

  3. Lipid and glucose alterations in perinatally-acquired HIV-infected adolescents and young adults

    BMC Infectious Diseases, Vol. 15, Núm. 1

2014

  1. Once-daily antiretroviral therapy in a cohort of HIV-infected children and adolescents

    Pediatric Infectious Disease Journal, Vol. 33, Núm. 10, pp. 1052-1054

2011

  1. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain

    Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 10, pp. 2362-2371

  2. First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: An open-label, randomised phase 2/3 trial

    The Lancet Infectious Diseases, Vol. 11, Núm. 4, pp. 273-283

2010

  1. Diagnóstico retrospectivo de una infección congénita por citomegalovirus en la sangre desecada de un neonato

    Enfermedades Infecciosas y Microbiologia Clinica